BioEcho Life Sciences announces FDA listing of its EchoLUTION Viral RNA/DNA Kit for nucleic acid extraction

November 27, 2023

The EchoLUTION Viral RNA/DNA Kit is now available for the US diagnosis market.
Based on a unique single centrifugation step, nucleic acid extraction is up to 65 % faster than standard methods.
With no organic solvents added and by efficient removal of inhibitors, the result is a high-quality viral RNA or DNA for downstream application.

Rapid and accurate clinical diagnostic tests are essential for the detection of viral infections and proper medical care. The EchoLUTION Viral RNA/DNA Kit is specifically designed for the extraction of viral nucleic acids from a variety of samples: It is particularly useful for the detection of respiratory viruses, as well as enteropathogenic viruses contained in stool samples. The kit is IVDR-compliant, CE-marked, and FDA-listed, making it an ideal solution for diagnostic laboratory routines that require high-quality standards. With a more sustainable composition it delivers the same performance as the previously available EchoLUTION Viral RNA/DNA Swab Kit Plus. This predecessor kit has been extensively used in Europe for rapid PCR diagnostics during the SARS-CoV-2 pandemic, with more than 12 million tests performed.

“BioEcho is proud to provide a product that enables convenient extraction of viral RNA and DNA. We believe these products, which are FDA-listed in the US, will have a significant impact on improving efficiency for diagnostics laboratories and ultimately decreasing response times for patients”, underlines Lydia Willing, General Manager at BioEcho Life Sciences, Inc.

One of the key benefits of the EchoLUTION Viral RNA/DNA Kit is its technology, which is based on a tailored lysis followed by nucleic acid purification in a single centrifugation step. For respiratory viruses, no incubation is needed, for stool samples it is as short as 10 minutes. This means that the purified viral RNA or DNA from 96 samples is ready to use within 20–30 minutes depending on the sample type (swabs in medium, dry swabs, or stool samples). The kit is available in different formats (48-and 96-well plates) to adapt laboratory throughput to demands. The product is compatible with a variety of downstream applications such as qPCR.

About BioEcho Life Sciences

BioEcho Life Sciences is a specialized solution provider for the extraction and analysis of nucleic acids. We create disruptive technologies, products, and workflows that make downstream processing of nucleic acids easier and faster, significantly increase throughput, and deliver reliable results. Our EchoLUTION technology enables the fastest DNA and RNA extraction on the market - in just one single step. It reduces the associated plastic consumption by up to 70 %.

BioEcho was founded in 2016 by leading industry experts. The headquarter in Cologne, Germany, is certified according to ISO 9001 and ISO 13485.

BioEcho. The Nucleic Acid Experts.

Press contact:

Christiane Schlottbom

Director Marketing

Office: +49 221 998897-42

E-Mail: christiane.schlottbom@bioecho.de